News

The patents are set to expire 2024-2026, the company said. The Mexican patent covers the uses of Tß4 to treat or prevent biological or immunological responses to reactive

Production at Boehringer Ingelheim’s Ben Venue Laboratories factory in Ohio, US, was stopped in November 2011 due to product quality issues. Ben Venue said it may resume operations

AmiKet is indicated for the treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathy in patients previously treated with taxane-based chemotherapy. According to the FDA, products with a

The company has also received another $5m milestone payment, which was triggered by the European Medicines Agency (EMA) acceptance of the marketing authorization application. Peginesatide is currently under

The study has met its objective of establishing bioequivalence to Zofran, the current approved reference listed drug. RedHill expects to file an application with the FDA for US

The study data demonstrated that CF101 is efficacious in preventing the clinical manifestations of Anterior Uveitis in an animal model. The study data support the utilization of CF101

Terms of the purchase have not been disclosed. Sigma-Aldrich expects this acquisition to be neutral to earnings per share in 2012. Research Organics will undergo transition into SAFC,

EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia. The product combines bupivacaine with DepoFoam, a product delivery technology that delivers medication over a

MDA translational research director Jane Larkindale said the grant will help to support further testing of CAT-1004 to assess the compound’s ability to counter muscle-damaging inflammation and support